JLABS@ TMC QuickFire Challenge
Residency at JLABS
Winners
Developing next-generation surgical adhesives based on polyurethane, which permit quick and safe wound closure, topically as well as inside the human body.
Aortix is a heart pump implanted without surgery, designed from the ground-up as a safe and effective treatment for chronic heart failure which affects one in five adults in the United States.
High-throughput antibody discovery platform for breast and other cancers focused on identifying therapeutics targeted at novel antigens induced by the tumor microenvironment.
Alterna Therapeutics, Inc.
Developing new therapeutics to treat diabetes and obesity.
The Challenge
In honor of the upcoming Grand Opening of JLABS @ TMC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ TMC community for one year.